LNP-RABVsaRNA-01 clinical trials

A clinical trial to assess whether a self-amplifying ribonucleic acid (saRNA) vaccine against Rabies viruses is safe and induces immune responses

This study is testing a new rabies vaccine (RAB-Vac) for the first time in humans. We want to check if it's safe and how your immune system reacts. It will involve healthy adults aged 18-50 and won't test if the vaccine protects against rabies.